Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The elderly, drugs, and cost control.

P P Lamy

    Drug Intelligence & Clinical Pharmacy
    |October 1, 1982
    PubMed
    Summary

    Geriatric drug therapy presents significant risks and requires better understanding. Current healthcare systems need reform to prioritize cost-effective, long-term care solutions over high-technology approaches.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diabetic patient compliance as a function of counseling. 1979.

    The Annals of pharmacotherapy·2006
    Same author

    Avoiding polypharmacy and iatrogenesis in the nursing home.

    Maryland medical journal (Baltimore, Md. : 1985)·1994
    Same author

    Understanding and managing Alzheimer's disease.

    The Journal of practical nursing·1993
    Same author

    Institutionalisation and drug use in older adults in the US.

    Drugs & aging·1993
    Same author

    Drug prescribing for the elderly.

    Archives of family medicine·1993
    Same author

    Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

    Drugs & aging·1991

    Area of Science:

    • Geriatric Medicine
    • Pharmacology
    • Healthcare Systems Analysis

    Background:

    • Geriatric drug therapy is complex and poses substantial risks to elderly patients.
    • Existing healthcare models often fail to adequately address the unique needs of older adults.
    • Current cost-efficiency measures in geriatric care are insufficient.

    Purpose of the Study:

    • To highlight the inadequacies in current geriatric drug therapy and healthcare systems.
    • To advocate for a shift towards more appropriate and cost-effective long-term care models for the elderly.
    • To propose a system redesign focused on procedural reimbursement rather than provider specialization.

    Main Methods:

    • This study is a conceptual analysis and review of existing literature on geriatric pharmacotherapy and healthcare economics.
    • It examines the limitations of high-technology and capital-intensive healthcare methods in long-term geriatric care.
    • The analysis focuses on the implications of current reimbursement structures on geriatric patient outcomes.

    Main Results:

    • Geriatric drug therapy is poorly understood and carries significant potential for harm.
    • Current healthcare systems are not optimally designed for cost-efficient, long-term geriatric care.
    • Reimbursement models often incentivize specialized procedures over comprehensive geriatric care.

    Conclusions:

    • A fundamental redesign of geriatric healthcare systems is necessary.
    • Future systems should prioritize cost-effectiveness, long-term care needs, and appropriate reimbursement strategies.
    • Moving away from high-technology dependence is crucial for improving geriatric drug therapy and care.

    Related Experiment Videos